Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease

Background/Aims Metabolic dysfunction-associated steatotic liver disease (MASLD) has become an increasingly important health challenge, with a substantial rise linked to changing lifestyles and global obesity. Ursolic acid, a natural pentacyclic triterpenoid, has been explored for its potential ther...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Yiyuan Zheng, Lina Zhao, Zhekun Xiong, Chaoyuan Huang, Qiuhong Yong, Dan Fang, Yugang Fu, Simin Gu, Chong Chen, Jiacheng Li, Yingying Zhu, Jing Liu, Fengbin Liu, Yong Li
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Korean Association for the Study of the Liver 2024-07-01
Saila:	Clinical and Molecular Hepatology
Gaiak:	metabolic dysfunction-associated steatotic liver disease ursolic acid secreted phosphoprotein 1 th17 cells
Sarrera elektronikoa:	http://e-cmh.org/upload/pdf/cmh-2024-0047.pdf
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!